Details for Patent: 7,763,635
✉ Email this page to a colleague
Summary for Patent: 7,763,635
| Title: | Once daily dosage forms of trospium |
| Abstract: | A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C.sub.min) and maximum (C.sub.max) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively. |
| Inventor(s): | Kidane; Argaw (Montgomery Village, MD), Flanner; Henry H. (Montgomery Village, MD), Bhatt; Padmanabh (Rockville, MD), Raoufinia; Arash (McLean, VA) |
| Assignee: | Supermus Pharmaceuticals, Inc. (Rockville, MD) |
| Application Number: | 11/889,985 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,763,635 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; Delivery; |
Drugs Protected by US Patent 7,763,635
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,763,635
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 493981 | ⤷ Sign Up | |||
| Australia | 2004289223 | ⤷ Sign Up | |||
| Canada | 2537103 | ⤷ Sign Up | |||
| Germany | 602004030931 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
